Skip to main content
Equibles

Yakira Capital Management, Inc.

Position in RNA — Atrium Therapeutics, Inc.

CIK 1584639 Westport, CT
Back to RNA Full portfolio

Position in RNA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,789,482
+$96,239 QoQ
Shares Held
133,047
+5.1% QoQ
Ownership
0.778%
of shares outstanding
% of Portfolio
0.62%
of 13F equity value
Holder Rank
#24
of 154 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RNA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Yakira Capital Management, Inc. holds $3,480,869 across 8 Biotechnology names. RNA ranks #1 (51.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RNA
Atrium Therapeutics, Inc.
This page 		133,047 $1,789,482
2 APGE
Apogee Therapeutics, Inc.
 6,000 $796,380
3 LSTA
Lisata Therapeutics, Inc.
 138,561 $471,107
4 TECH
BIO-TECHNE Corp
 6,000 $423,900
5 ESLA
Estrella Immunopharma, Inc.
 46,285 $0
6
10,311 $0
7 TVGN
Tevogen Inc.
 65,128 $0
8 VRXA
Veraxa Biotech AG - Post de-SPAC
 98,360 $0

All Filings in RNA

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,789,482 133,047
2026-03-31 $1,693,243 126,645